News
MeMed Bacterial-Viral Blood Test Trialed in UK
BBC Radio Highlights MeMed BV’s Role in the NHS-Funded Trial Aimed at Improving Diagnosis in Children with Suspected Infections. {from minute 19:28}
NHS Trialling Rapid Blood Test to Help Diagnose Sepsis and Meningitis in Children
Data on the utility of MeMed BV to be presented at ACEP25
New Sepsis Testing Tools Emerging While Adoption Drags Amid Clinical Utility Concerns
More than 100,000 patients tested with MeMed BV
MeMed: Beat Müller, Dave Hickey, David Shulkin
FDA Grants Breakthrough Designation Status for Test for Patients with Suspected Sepsis
MeMed BV Test Demonstrates Antibiotic Overuse Reduction in First US Interventional Trial
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief
Trial shows MeMed BV reduces use of unnecessary antibiotics
Determining If the Patient’s Infection is Bacterial or Viral
Know Thy Enemy: MeMed’s Diagnostic Reduces Antibiotic Overuse in U.S. Trial
Maccabi Healthcare Services Announces it is the First HMO in the World to Include…
DiaSorin receives FDA 510(K) clearance for Its LIAISON MeMed BV test
MeMed raises $93M to accelerate commercialization of its host immune-response…
Maimonides Medical Center adopts revolutionary technology that quickly..
After a decade and 130 million dollars, the MeMed test receives FDA clearance
2021 Dun & Bradstreet’s Best Companies to Work For
Platform distinguishing between viral and bacterial infections cleared by FDA…
FDA Clears New Technology to Differentiate Bacterial, Viral Infections Using Biomarkers
Bacterial and Viral Biomarker Test Gains US FDA Clearance
MeMed Gets FDA 510(k) Clearance for Test Distinguishing Between…
Israel’s MeMed gets FDA approval for ‘breakthrough’ infection test
MeMed Received FDA Clearance for Infection Test
FDA clears MeMed’s point-of-need infectious disease test
US approves MeMed test to distinguish bacterial from viral infections
MeMed’s Diagnostics, BV Test and Key Platform Get 510(k) Clearance
Rapid test to distinguish bacterial and viral infections wins US approval
Pioneering test which can indicate COVID-19 severity receives CE Mark
COVID-19 severity test is approved for sale in the UK
Longitude Prize: Bacterial or Viral: To Treat or Not to Treat with Antibiotics
Test predicting COVID-19 severity receives CE mark
MeMed’s Covid-19 severity test receives its CE Mark to predict severe outcomes
MeMed Wins $4.1M DOD Grant toward Manufacturing of POC Platform
MeMed Receives CE Mark for Diagnostic Platform & Infection Assay
MeMed’s co-founder and CEO, Dr. Eran Eden on the BioBoss Podcast
Israeli firm advances diagnostic solutions for Covid-19
Interview with Eran Eden, MeMed’s CEO
Israeli Startups Join The Fight Against Coronavirus
OurCrowd Portfolio Companies Pivot to Tackle Coronavirus Pandemic
Technology Pioneers 2019
Rapid blood test to ‘cut antibiotic use’
A New Blood Test Could Stop Doctors From Overprescribing Antibiotics
No results found.